vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and BXP, Inc. (BXP). Click either name above to swap in a different company.
APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $872.1M, roughly 1.1× BXP, Inc.). BXP, Inc. runs the higher net margin — 15.3% vs 7.7%, a 7.5% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 0.8%). Over the past eight quarters, APTARGROUP, INC.'s revenue compounded faster (2.6% CAGR vs 1.3%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
BXP Inc., operating as Boston Properties, is a leading U.S. real estate investment trust focused on owning, managing and developing high-quality Class A commercial office properties across major U.S. metro markets, serving diverse corporate, tech and professional service tenants.
ATR vs BXP — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $872.1M |
| Net Profit | $74.3M | $133.0M |
| Gross Margin | — | — |
| Operating Margin | 11.0% | — |
| Net Margin | 7.7% | 15.3% |
| Revenue YoY | 13.5% | 0.8% |
| Net Profit YoY | -26.4% | 53.0% |
| EPS (diluted) | $1.13 | $1.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $872.1M | ||
| Q4 25 | $962.7M | $877.1M | ||
| Q3 25 | $961.1M | $871.5M | ||
| Q2 25 | $966.0M | $868.5M | ||
| Q1 25 | $887.3M | $865.2M | ||
| Q4 24 | $848.1M | $858.6M | ||
| Q3 24 | $909.3M | $859.2M | ||
| Q2 24 | $910.1M | $850.5M |
| Q1 26 | — | $133.0M | ||
| Q4 25 | $74.3M | $248.4M | ||
| Q3 25 | $127.9M | $-121.7M | ||
| Q2 25 | $111.7M | $89.0M | ||
| Q1 25 | $78.8M | $61.2M | ||
| Q4 24 | $100.9M | $-228.9M | ||
| Q3 24 | $100.0M | $83.6M | ||
| Q2 24 | $90.5M | $79.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 58.8% | ||
| Q3 25 | — | 59.3% | ||
| Q2 25 | — | 59.2% | ||
| Q1 25 | — | 59.2% | ||
| Q4 24 | — | 59.7% | ||
| Q3 24 | — | 59.5% | ||
| Q2 24 | — | 59.8% |
| Q1 26 | — | — | ||
| Q4 25 | 11.0% | — | ||
| Q3 25 | 14.2% | — | ||
| Q2 25 | 14.9% | — | ||
| Q1 25 | 12.8% | — | ||
| Q4 24 | 14.2% | — | ||
| Q3 24 | 15.2% | — | ||
| Q2 24 | 13.8% | — |
| Q1 26 | — | 15.3% | ||
| Q4 25 | 7.7% | 28.3% | ||
| Q3 25 | 13.3% | -14.0% | ||
| Q2 25 | 11.6% | 10.2% | ||
| Q1 25 | 8.9% | 7.1% | ||
| Q4 24 | 11.9% | -26.7% | ||
| Q3 24 | 11.0% | 9.7% | ||
| Q2 24 | 9.9% | 9.4% |
| Q1 26 | — | $1.69 | ||
| Q4 25 | $1.13 | $1.56 | ||
| Q3 25 | $1.92 | $-0.77 | ||
| Q2 25 | $1.67 | $0.56 | ||
| Q1 25 | $1.17 | $0.39 | ||
| Q4 24 | $1.48 | $-1.46 | ||
| Q3 24 | $1.48 | $0.53 | ||
| Q2 24 | $1.34 | $0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | $512.8M |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $2.7B | $7.7B |
| Total Assets | $5.3B | $25.1B |
| Debt / EquityLower = less leverage | 0.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $512.8M | ||
| Q4 25 | $409.5M | $1.5B | ||
| Q3 25 | $264.8M | $861.1M | ||
| Q2 25 | $169.8M | $447.0M | ||
| Q1 25 | $136.8M | $398.1M | ||
| Q4 24 | $226.2M | $1.3B | ||
| Q3 24 | $327.9M | $1.4B | ||
| Q2 24 | $223.9M | $685.4M |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — |
| Q1 26 | — | $7.7B | ||
| Q4 25 | $2.7B | $5.1B | ||
| Q3 25 | $2.8B | $5.0B | ||
| Q2 25 | $2.7B | $5.3B | ||
| Q1 25 | $2.5B | $5.3B | ||
| Q4 24 | $2.5B | $5.4B | ||
| Q3 24 | $2.5B | $5.8B | ||
| Q2 24 | $2.4B | $5.8B |
| Q1 26 | — | $25.1B | ||
| Q4 25 | $5.3B | $26.2B | ||
| Q3 25 | $5.1B | $26.0B | ||
| Q2 25 | $4.9B | $25.6B | ||
| Q1 25 | $4.5B | $25.4B | ||
| Q4 24 | $4.4B | $26.1B | ||
| Q3 24 | $4.6B | $26.4B | ||
| Q2 24 | $4.5B | $25.5B |
| Q1 26 | — | — | ||
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | — |
| Free Cash FlowOCF − Capex | $96.9M | — |
| FCF MarginFCF / Revenue | 10.1% | — |
| Capex IntensityCapex / Revenue | 9.0% | 1.5% |
| Cash ConversionOCF / Net Profit | 2.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $183.7M | $407.8M | ||
| Q3 25 | $177.6M | $274.2M | ||
| Q2 25 | $126.0M | $353.1M | ||
| Q1 25 | $82.7M | $210.0M | ||
| Q4 24 | $178.2M | $383.7M | ||
| Q3 24 | $229.3M | $286.1M | ||
| Q2 24 | $143.6M | $367.1M |
| Q1 26 | — | — | ||
| Q4 25 | $96.9M | $362.7M | ||
| Q3 25 | $114.3M | $231.6M | ||
| Q2 25 | $62.5M | $281.5M | ||
| Q1 25 | $25.9M | $152.6M | ||
| Q4 24 | $112.2M | $312.5M | ||
| Q3 24 | $162.7M | $234.5M | ||
| Q2 24 | $75.4M | $332.4M |
| Q1 26 | — | — | ||
| Q4 25 | 10.1% | 41.4% | ||
| Q3 25 | 11.9% | 26.6% | ||
| Q2 25 | 6.5% | 32.4% | ||
| Q1 25 | 2.9% | 17.6% | ||
| Q4 24 | 13.2% | 36.4% | ||
| Q3 24 | 17.9% | 27.3% | ||
| Q2 24 | 8.3% | 39.1% |
| Q1 26 | — | 1.5% | ||
| Q4 25 | 9.0% | 5.1% | ||
| Q3 25 | 6.6% | 4.9% | ||
| Q2 25 | 6.6% | 8.2% | ||
| Q1 25 | 6.4% | 6.6% | ||
| Q4 24 | 7.8% | 8.3% | ||
| Q3 24 | 7.3% | 6.0% | ||
| Q2 24 | 7.5% | 4.1% |
| Q1 26 | — | — | ||
| Q4 25 | 2.47× | 1.64× | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.13× | 3.97× | ||
| Q1 25 | 1.05× | 3.43× | ||
| Q4 24 | 1.77× | — | ||
| Q3 24 | 2.29× | 3.42× | ||
| Q2 24 | 1.59× | 4.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
BXP
| Lease | $818.2M | 94% |
| Parking and other | $30.8M | 4% |
| Development and management services | $9.2M | 1% |
